Monday, January 12, 2026 7:02:28 AM
FDA compares apples to apples, not junk science apples to oranges comparisons. The Zr90/Y90 ratios are part of those comparisons because it may vary well impact product efficacy. The high initial Y90 concentrations needed to ship product to Indian certainly effect product viscosity, which yield another bogus apples to oranges comparison between any India trials and what RDGL seeks to market in USA. That brings up another advantage of encapsulated Y90 vs. what RDGL is doing: initial Y90 concentration within microspheres doesn't impact viscosity of injectable gel carrier.
It all gets back to why RDGL went to India in first place before Indian health authorities put a stop to RDGL's dangerous nonsense: They don't have controlled and monitored, statistically valid animal demo that product works and works safely at clinical doses needed to kill treated tumors. Without that, there's no path to human trials in USA. Now it looks like RDGL is at same dead end in India too.
What happened with that second set of rabbits at JHU Vet School in 2023? Occam says it was a disaster that MK buried and MK keeps trying to put lipstick on a pig.
By all appearances, after decades of "effort", Radiogel is snake oil and RDGL is a scam
It all gets back to why RDGL went to India in first place before Indian health authorities put a stop to RDGL's dangerous nonsense: They don't have controlled and monitored, statistically valid animal demo that product works and works safely at clinical doses needed to kill treated tumors. Without that, there's no path to human trials in USA. Now it looks like RDGL is at same dead end in India too.
What happened with that second set of rabbits at JHU Vet School in 2023? Occam says it was a disaster that MK buried and MK keeps trying to put lipstick on a pig.
By all appearances, after decades of "effort", Radiogel is snake oil and RDGL is a scam
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
